Prilosec OTC Formulation Targeted In Mylan Labs Suit
This article was originally published in The Tan Sheet
Executive Summary
Mylan Laboratories' lawsuit against Procter & Gamble over the formulation of Prilosec OTC is the most recent in a string of challenges for the over-the-counter heartburn medication